Chromocell Therapeutics Corp [Rocket]

Overview

Chromocell Therapeutics Corp

Recent News + Filings (All items)

Date Filed	Type	Description
07/19/2023	S-1/A	Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
06/30/2023	S-1/A	Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
05/01/2023	S-1/A	Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
01/20/2023	S-1/A	Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
01/11/2023	S-1	Form S-1 - General form for registration of securities under the Securities Act of 1933:

Revenue Mix by Segment

Financial Summary (All financials)

In millions, except per share items	Dec-31-22	Dec-31-21	Dec-31-20
Revenues	0.0	0.0	0.2
Revenue growth		-100.0%
Cost of goods sold	0.0	0.0	0.0
Gross profit	0.0	0.0	0.2
Gross margin			100.0%
Selling, general and administrative	1.9	0.6	1.4
Research and development	0.4	0.2	0.1
General and administrative	1.1	0.5	1.3
EBIT	-2.3	-0.8	-2.0
EBIT margin			-1024.8%
Pre-tax income	-2.5	-0.6	-0.7
Income taxes	0.0	0.0	0.0
Tax rate	0.0%	0.0%	0.0%
Net income	-2.5	-0.6	-0.7
Net margin			-330.4%

Diluted EPS	($0.63)
Shares outstanding (diluted)	3.9

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.